Vermeiden Sie Betrug, informieren Sie sich und finden Sie das Beste
Legal Name: ROCK SPRINGS CAPITAL MANAGEMENT LP
Berichtszeitraum:
Jun 30, 2019
Gültigkeitsdatum:
Aug 14, 2019
Sicherheit |
Gehaltene Aktien / Nennbetrag |
Marktwert |
Möglichkeit |
UNITEDHEALTH GRP INC (91324P102)
|
591,000 |
$144,210k |
|
GW PHARMACEUTICALS PLC ADS (36197T103)
|
605,000 |
$104,296k |
|
WELLCARE HEALTH PLANS INC (94946T106)
|
320,500 |
$91,365k |
|
B. Riley Wealth Management, Inc. (023111206)
|
4,525,000 |
$87,740k |
|
Neurocrine Biosciences Inc. (64125C109)
|
1,023,000 |
$86,372k |
|
INTUITIVE SURGIC INC (46120E602)
|
152,500 |
$79,994k |
|
HCA HEALTHCARE (40412C101)
|
455,000 |
$61,502k |
|
PACIRA BIOSCIENCES (695127100)
|
1,250,000 |
$54,363k |
|
SPARK THERAPEUTICS INC (84652J103)
|
505,371 |
$51,740k |
|
Encompass Health Corp (29261A100)
|
805,000 |
$51,005k |
|
Sarepta Therapeutics Inc (803607100)
|
325,000 |
$49,384k |
|
Bristol-Myers Squibb Co (110122108)
|
1,050,000 |
$47,618k |
|
EXACT SCIENCES CORP (30063P105)
|
397,000 |
$46,862k |
|
TELEFLEX INC (879369106)
|
130,000 |
$43,050k |
|
BOSTON SCIENTIFIC (101137107)
|
970,000 |
$41,691k |
|
COHERUS BIOSCIENCES INC (19249H103)
|
1,880,000 |
$41,548k |
|
IRHYTHM TECHNOLOGIES INC COM (450056106)
|
499,615 |
$39,510k |
|
PENUMBRA INC COM (70975L107)
|
239,000 |
$38,240k |
|
Vertex Pharmaceuticals Inc (92532F100)
|
203,000 |
$37,226k |
|
ACADIA HEALTHCARE CO INC (00404A109)
|
1,055,000 |
$36,872k |
|
Ultragenyx Pharmaceutical Inc (90400D108)
|
580,000 |
$36,830k |
|
STRYKER CORP (863667101)
|
179,000 |
$36,799k |
|
EDWARDS LIFESCIENCE (28176E108)
|
183,500 |
$33,900k |
|
IDEXX LABS INC (45168D104)
|
120,200 |
$33,095k |
|
ALEXION PHARMACEUTICALS INC CO (015351109)
|
242,500 |
$31,763k |
|
RADIUS HEALTH INC (750469207)
|
1,250,000 |
$30,450k |
|
MOLINA HEALTHCARE INC (60855R100)
|
206,000 |
$29,487k |
|
INSULET CORP COM (45784P101)
|
244,500 |
$29,188k |
|
MEDICINES CO (584688105)
|
800,000 |
$29,176k |
|
BLUEPRINT MEDICINES CORP (09627Y109)
|
307,500 |
$29,006k |
|
ADAPTIVE BIOTECHNOLOGIES COR (00650F109)
|
600,000 |
$28,980k |
|
ALIGN TECHNOLOGY INC (016255101)
|
105,000 |
$28,739k |
|
CIGNA CORP (125523100)
|
182,300 |
$28,721k |
|
Portola Pharmaceuticals Inc (737010108)
|
1,008,000 |
$27,347k |
|
MADRIGAL PHARMACEUTICALS INC (558868105)
|
256,900 |
$26,926k |
|
BEIGENE LTD-ADR (07725L102)
|
214,800 |
$26,624k |
|
Incyte Corp (45337C102)
|
312,300 |
$26,533k |
|
Invitae Corp (46185L103)
|
1,125,000 |
$26,438k |
|
Argenx SE Sponsored ADR (04016X101)
|
181,700 |
$25,725k |
|
BAXTER INTL INC (071813109)
|
300,700 |
$24,627k |
|
ASCENDIS PHARMA A S (04351P101)
|
213,500 |
$24,585k |
|
RA PHARMACEUTICALS (74933V108)
|
804,000 |
$24,176k |
|
PRA Health Science (69354m108)
|
240,000 |
$23,796k |
|
Thermo Fisher Scientific Inc (883556102)
|
81,000 |
$23,788k |
|
ALNYLAM PHARMACEUTICALS INC (02043Q107)
|
327,700 |
$23,778k |
|
EPIZYME INC (29428V104)
|
1,850,100 |
$23,219k |
|
BIOGEN INC (09062X103)
|
97,500 |
$22,802k |
Call |
INSMED INC (457669307)
|
890,000 |
$22,784k |
|
GALAPAGOS NV (36315X101)
|
165,000 |
$21,273k |
|
MIRATI THERAPEUTICS INC (60468T105)
|
202,500 |
$20,858k |
|
COLLEGIUM PHARMACEUTICAL INC (19459J104)
|
1,577,893 |
$20,749k |
|
ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (98887Q104)
|
550,000 |
$19,179k |
|
RETROPHIN INC COM (761299106)
|
950,000 |
$19,086k |
|
PHASEBIO PHARMACEUTICALS INC (717224109)
|
1,423,256 |
$18,673k |
|
ALDER BIOPHARMACEUTICALS INC (014339105)
|
1,562,300 |
$18,388k |
|
Intersect ENT Inc. (46071F103)
|
790,000 |
$17,980k |
|
ALLAKOS INC COM (01671P100)
|
404,000 |
$17,505k |
|
WEST PHARMACEUT SVS (955306105)
|
137,500 |
$17,208k |
|
CELGENE CORP (151020104)
|
185,150 |
$17,115k |
|
Sage Therapeutics Inc (78667J108)
|
92,500 |
$16,936k |
|
SEATTLE GENETICS INC (812578102)
|
242,000 |
$16,749k |
|
Guardant Health Inc (40131M109)
|
190,000 |
$16,403k |
|
AXONICS MODULATION TECH INC (05465P101)
|
400,000 |
$16,388k |
|
ODONATE THERAPEUTICS INC (676079106)
|
430,000 |
$15,777k |
|
AUDENTES THERAPEUTICS INC COM (05070R104)
|
410,000 |
$15,523k |
|
BIOHAVEN PHARMACTL HLDG CO L (G11196105)
|
343,500 |
$15,042k |
|
GLOBAL BLOOD THERAPEUTICS IN (37890U108)
|
265,000 |
$13,939k |
|
FIBROGEN INC (31572Q808)
|
306,000 |
$13,825k |
|
AGILENT TECHNOLOGIES INC (00846U101)
|
182,800 |
$13,650k |
|
TRANSLATE BIO INC (89374L104)
|
1,009,179 |
$12,746k |
|
NEVRO CORP COM (64157F103)
|
195,500 |
$12,674k |
|
OBSEVA SA (H5861P103)
|
1,120,000 |
$12,667k |
|
AMICUS THERAPEUTICS INC (03152W109)
|
1,000,000 |
$12,480k |
|
IMMUNOMEDICS INC (452907108)
|
895,000 |
$12,414k |
|
NOVOCURE LTD (G6674U108)
|
195,000 |
$12,330k |
|
Anaptysbio Inc (032724106)
|
218,500 |
$12,328k |
|
BIOMARIN PHARMACEUTICAL INC (09061G101)
|
142,500 |
$12,205k |
|
AXOGEN INC COM (05463X106)
|
603,970 |
$11,959k |
|
ZOGENIX INC (98978L204)
|
235,000 |
$11,228k |
|
RIGEL PHARMACEUTICL (766559603)
|
4,200,000 |
$10,962k |
|
ABBVIE INC (00287Y109)
|
150,000 |
$10,908k |
|
FRESHPET INC COM (358039105)
|
235,000 |
$10,695k |
|
THERAVANCE BIOPHARMA INC (G8807B106)
|
550,000 |
$8,982k |
|
AGIOS PHARMACEUTICALS INC (00847X104)
|
170,500 |
$8,505k |
|
Homology Medicines (438083107)
|
425,000 |
$8,317k |
|
RTI BIOLOGICS INC COM (74975N105)
|
1,950,000 |
$8,288k |
|
KARUNA THERAPEUTICS INC (48576A100)
|
413,500 |
$8,278k |
|
ACHILLION PHARMACEUTICALS (00448Q201)
|
2,950,000 |
$7,906k |
|
Assembly Biosciences Inc (045396108)
|
560,000 |
$7,554k |
|
DERMIRA INC (24983L104)
|
775,000 |
$7,409k |
|
PUMA BIOTECHNOLOGY INC (74587V107)
|
534,400 |
$6,792k |
|
CymaBay Therapeutics, Inc. (23257D103)
|
900,000 |
$6,444k |
|
SPERO THERAPEUTICS INC (84833T103)
|
525,000 |
$6,043k |
|
Bluebird Bio Inc (09609G100)
|
47,000 |
$5,978k |
|
INSMED INC (457669AA7)
|
6,000,000 |
$5,849k |
|
MERSANA THERAPEUTICS INC (59045L106)
|
1,400,000 |
$5,670k |
|
ANTHEM INC (036752103)
|
20,000 |
$5,644k |
|
AEGLEA BIOTHERAPEUTICS INC (00773J103)
|
800,000 |
$5,480k |
|
ARDELYX INC (039697107)
|
2,000,000 |
$5,380k |
|
GLOBAL CORD BLOOD CORPORATIO (G39342103)
|
925,000 |
$5,347k |
|
Rhythm Pharmaceuticals, Inc. (76243J105)
|
235,000 |
$5,170k |
|
NGM BIOPHARMACEUTICALS INC (62921N105)
|
351,100 |
$5,140k |
|
MACROGENICS INC (556099109)
|
300,000 |
$5,091k |
|
GAMIDA CELL LTD (M47364100)
|
1,000,000 |
$5,080k |
|
MEDICINES CO/THE (584688AG0)
|
5,000,000 |
$5,026k |
|
Momenta Pharmaceutical Inc. (60877T100)
|
400,000 |
$4,980k |
|
CHIASMA INC (16706W102)
|
650,000 |
$4,856k |
|
ALDER BIOPHARMACEUTICALS INC (014339AA3)
|
5,000,000 |
$4,672k |
|
ACLARIS THERAPEUTICS INC (00461U105)
|
2,028,000 |
$4,441k |
|
AKERO THERAPEUTICS INC (00973Y108)
|
225,000 |
$4,309k |
|
Compugen Ltd (M25722105)
|
1,100,000 |
$4,224k |
|
RESTORBIO INC (76133L103)
|
400,000 |
$4,080k |
|
MYOVANT SCIENCES (G637AM102)
|
450,000 |
$4,073k |
|
INTERCEPT PHARMACEUTICALS (45845P108)
|
50,000 |
$3,979k |
|
LA JOLLA PHARMACEUTICAL CO (503459604)
|
425,000 |
$3,931k |
|
NABRIVA THERAPEUTICS PLC SHS (G63637105)
|
1,600,000 |
$3,888k |
|
CLOVIS ONCOLOGY INC COM (189464100)
|
256,000 |
$3,807k |
|
MEDICINES CO (584688AE5)
|
3,000,000 |
$3,618k |
|
ADAPTIMMUNE THERAPEUTICS PLC (00653A107)
|
875,000 |
$3,518k |
|
ARVINAS INC (04335A105)
|
150,000 |
$3,299k |
|
FIVE PRIME THERAPEUTICS INC (33830X104)
|
526,100 |
$3,172k |
|
DYNAVAX TECHNOLOGIES CORP (268158201)
|
650,000 |
$2,594k |
|
CORREVIO PHARMA CORP (22026V105)
|
1,200,000 |
$2,592k |
|
Paratek (699374302)
|
450,000 |
$1,796k |
|
CORVUS PHARMACEUTICALS INC (221015100)
|
400,000 |
$1,496k |
|
RADIUS HEALTH INC (750469AA6)
|
1,500,000 |
$1,361k |
|
NBIX 2 1/4 5/15/24 (64125CAD1)
|
1,000,000 |
$1,317k |
|
TBPH 3 1/4 11/1/23 (88339KAA0)
|
1,500,000 |
$1,290k |
|
KALEIDO BIOSCIENCES INC (483347100)
|
100,050 |
$1,161k |
|
PCRX 2 3/8 4/1/22 (695127AD2)
|
1,000,000 |
$1,026k |
|
Novavax, Inc. (670002401)
|
162,500 |
$952k |
|
DERMIRA INC (24983LAB0)
|
1,000,000 |
$865k |
|
COVETRUS INC (22304C100)
|
32,231 |
$788k |
|
HERON THERAPEUTICS INC (427746102)
|
30,000 |
$558k |
|
PROTEOSTASIS THERAPEUTICS IN (74373B109)
|
400,000 |
$390k |
|
Viele Menschen wurden durch Betrug und Ponzi-Vorhaben verbrannt. Deshalb haben wir diese Website erstellt, um Ihnen als potenziellem Investor dabei zu helfen, die Fakten zu ermitteln, die besten zu finden und Betrugs- und Ponzi-Vorhaben zu vermeiden.
Alle auf dieser Website bereitgestellten Informationen werden ohne Gewähr und nur zu Informationszwecken bereitgestellt.
InvestingReview.org bietet keine Anlageberatung an. InvestingReview.org ist kein Anlageberater und wird von keiner US-amerikanischen oder nicht US-amerikanischen Aufsichtsbehörde unterstützt oder ist mit dieser verbunden.
Kürzlich gesuchte Firmen
Bitte beachten Sie: Die Suchdaten werden von Dritten gesammelt und einmal täglich aktualisiert.